India looking to be self-reliant in development, production of vaccine against Covid-19

Credit: IndiaTimes- Published on November 30, 2020
While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass production of Covishield vaccine developed by Oxford -Astra Zeneca. A total of 10 vaccine candidates have been supported by Department of Biotechnology so far at both academia and industry and...

You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions


Serum Institute of India

Indian biotechnological company, vaccine manufacturer
With this, Maldives (along with Bhutan) has become the first recipient of India's gift of the Covishield vaccines, manufactured by the Serum Institute of India..
Credit: IndiaTimes - Published 13 hours ago




Related videos from verified sources

'Covaxin phase-3 trial probably largest clinical trial in India': Principal Investigator 01:36
Credit: ANI - Published on November 21, 2020 


Watch: PM Modi holds review meeting to discuss Indiaโ€™s vaccine strategy 03:20
Credit: HT Digital Content - Published on November 21, 2020 


'Role of pollution in higher Covid deaths...': Delhi CM Kejriwal #HTLS2020 05:11
Credit: HT Digital Content - Published on November 21, 2020 


Related news from verified sources

While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass production of...
on November 30, 2020 • IndiaTimes

The government has initiated a robust COVID-19 vaccine manufacturing and delivery ecosystem to meet the demand, Science and Technology Minister Harsh Vardhan...
on November 26, 2020 • Mid-Day

You might like